Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
66.67%
0%
66.67%
6 Months
100.0%
0%
100.0%
1 Year
72.41%
0%
72.41%
2 Years
61.29%
0%
61.29%
3 Years
488.24%
0%
488.24%
4 Years
-50.98%
0%
-50.98%
5 Years
-86.19%
0%
-86.19%
Sona Nanotech, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
6.97%
EBIT to Interest (avg)
-4.37
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.31
Sales to Capital Employed (avg)
0
Tax Ratio
4.18%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
65.00
EV to EBIT
-19.48
EV to EBITDA
-24.83
EV to Capital Employed
65.05
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-333.95%
ROE (Latest)
-328.95%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot : Oct 2014
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.02%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Apr'25 - YoY
Apr'25
Apr'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.70
-0.60
-16.67%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-0.90
-0.80
-12.50%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
YoY Growth in quarter ended Apr 2025 is 0.00% vs 0.00% in Apr 2024
Consolidated Net Profit
YoY Growth in quarter ended Apr 2025 is -12.50% vs -60.00% in Apr 2024
Annual Results Snapshot (Consolidated) - Oct'24
Oct'24
Oct'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-2.20
-2.40
8.33%
Interest
0.00
0.10
-100.00%
Exceptional Items
0.20
0.10
100.00%
Consolidate Net Profit
-2.70
-2.50
-8.00%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
YoY Growth in year ended Oct 2024 is 0.00% vs 0.00% in Oct 2023
Consolidated Net Profit
YoY Growth in year ended Oct 2024 is -8.00% vs -4.17% in Oct 2023
About Sona Nanotech, Inc. 
Sona Nanotech, Inc.
Specialty Chemicals
Sona Nanotech Inc. is a nanotechnology life sciences company. The principal business is the development and application of its technology for use in multiplex diagnostic testing platforms. The Company offers a suite of products and services for multiple applications, including custom conjugation, lateral flow test development, lateral flow test production, point of care diagnostics, drug delivery, photo-thermal therapy and cell imaging. The Company’s products include Lateral flow. Its Lateral flow is a technology and a paper-based diagnostic test used to confirm the presence or absence of a target analyte in a sample without the need for specialist lab equipment. Lateral flow tests are used in various sectors, which include animal and veterinary health, food and drink, environmental testing, agricultural testing, and drugs of abuse.
Company Coordinates 
Company Details
Purdy's Wharf Tower 2, 1969 Upper Water St Suite 2001 HALIFAX NS : B3J 3R7
Registrar Details






